Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Antiviral Drugs Market, by Region, 2018-2027 (USD Billion)
1.2.2. Antiviral Drugs Market, by Type, 2018-2027 (USD Billion)
1.2.3. Antiviral Drugs Market, by Application, 2018-2027 (USD Billion)
1.2.4. Antiviral Drugs Market, by Drug Class, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Antiviral Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Antiviral Drugs Market Dynamics
3.1. Antiviral Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Antiviral Drugs Market Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Antiviral Drugs Market, by Type
5.1. Market Snapshot
5.2. Global Antiviral Drugs Market by Type, Performance - Potential Analysis
5.3. Global Antiviral Drugs Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4. Antiviral Drugs Market, Sub Segment Analysis
5.4.1. Branded
5.4.2. Generics
Chapter 6. Global Antiviral Drugs Market, by Application
6.1. Market Snapshot
6.2. Global Antiviral Drugs Market by Application, Performance - Potential Analysis
6.3. Global Antiviral Drugs Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Antiviral Drugs Market, Sub Segment Analysis
6.4.1. HIV
6.4.2. Hepatitis
6.4.3. Herpes
6.4.4. Influenza
6.4.5. Others
Chapter 7. Global Antiviral Drugs Market, by Drug Class
7.1. Market Snapshot
7.2. Global Antiviral Drugs Market by Drug Class - Potential Analysis
7.3. Global Antiviral Drugs Market Estimates & Forecasts by Drug Class 2017-2027 (USD Billion)
7.4. Antiviral Drugs Market, Sub Segment Analysis
7.4.1. DNA Polymerase Inhibitors
7.4.2. Reverse Transcriptase Inhibitors
7.4.3. Protease Inhibitors
7.4.4. Neuraminidase Inhibitors
7.4.5. Others
Chapter 8. Global Antiviral Drugs Market, Regional Analysis
8.1. Antiviral Drugs Market, Regional Market Snapshot
8.2. North America Antiviral Drugs Market
8.2.1. U.S. Antiviral Drugs Market
8.2.1.1. Type breakdown estimates & forecasts, 2017-2027
8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
8.2.1.3. Drug Class breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Antiviral Drugs Market
8.3. Europe Antiviral Drugs Market Snapshot
8.3.1. U.K. Antiviral Drugs Market
8.3.2. Germany Antiviral Drugs Market
8.3.3. France Antiviral Drugs Market
8.3.4. Spain Antiviral Drugs Market
8.3.5. Italy Antiviral Drugs Market
8.3.6. Rest of Europe Antiviral Drugs Market
8.4. Asia-Pacific Antiviral Drugs Market Snapshot
8.4.1. China Antiviral Drugs Market
8.4.2. India Antiviral Drugs Market
8.4.3. Japan Antiviral Drugs Market
8.4.4. Australia Antiviral Drugs Market
8.4.5. South Korea Antiviral Drugs Market
8.4.6. Rest of Asia Pacific Antiviral Drugs Market
8.5. Latin America Antiviral Drugs Market Snapshot
8.5.1. Brazil Antiviral Drugs Market
8.5.2. Mexico Antiviral Drugs Market
8.6. Rest of The World Antiviral Drugs Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Gilead Sciences
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. F. Hoffmann-La Roche AG
9.2.3. GlaxoSmithKline plc.
9.2.4. AbbVie
9.2.5. Merck & Co., Inc.
9.2.6. Johnson & Johnson Services, Inc.
9.2.7. Bristol-Myers Squibb Company
9.2.8. Cipla Inc.
9.2.9. Aurobindo Pharma
9.2.10. Dr. Reddys Laboratories Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption